Proteome Sciences has developed in-vitro assays to treat allergies associated with the skin and respiratory system that are induced by chemical compounds and substances.

Using PS Biomarker Services platform, Proteome identified and filed patents for more than 100 biomarkers from cells in the immune system and another 100 biomarkers from skin cells.

Proteome Sciences chief executive Christopher Pearce said that the eight TMT-SRM assays they selected have good performance and correlation with the discovery data.

"Most importantly, the biomarker assays developed provide an in-vitro alternative to animal testing that will become mandatory across the EU," Pearce said.

The company expects the biomarkers it has identified will lead to a number of industrial testing products and service contracts.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.